Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 1999
This is a Phase III open-labed, multicenter, prospective, randomised study, and comparative 3-arms of 140 patients (i.e. 420 total patients). Study period (date of first inclusion/last inclusion): 3 years Treatment period : 3 months
Epistemonikos ID: d3345d414cfce4e1296d3ad731b528d9d69f75fd
First added on: Jun 08, 2022